X0708 D LIVE 0001924725 Myris Therapeutics, Inc. 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 412-816-5315 DELAWARE BioHybrid Solutions Holdings, Inc. Biohybrid Solutions Holdings, Inc. Corporation true 2022 Laura E. Benjamin 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Executive Officer Director Rebecca Wolfe 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Executive Officer Antonina Simakova 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Executive Officer Alan Russell 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Promoter David N. Colaizzi 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Director Barbara S. Fox 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Director Krzysztof Matyjaszewski 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Director Mark A. Murcko 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Director Biotechnology Decline to Disclose 06b false 2026-09-01 false true Convertible Promissory Notes false 0 4500000 500000 4000000 false 4 0 0 0 false Myris Therapeutics, Inc. /s/ Laura E. Benjamin Laura E. Benjamin President and Chief Executive Officer 2026-10-14